Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016, Article ID 6909085, 9 pages
http://dx.doi.org/10.1155/2016/6909085
Research Article

Synthesis of Cefixime and Azithromycin Nanoparticles: An Attempt to Enhance Their Antimicrobial Activity and Dissolution Rate

1Department of Pharmacy, Sarhad University of Science and Technology, Peshawar, Pakistan
2Department of Chemistry, University of Malakand, Chakdara, Dir (Lower), Khyber Pakhtunkhwa 18000, Pakistan

Received 17 June 2016; Revised 22 September 2016; Accepted 10 October 2016

Academic Editor: Victor M. Castaño

Copyright © 2016 Farhat Ali Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Martindale, The Complete Drug Reference, Pharmaceutical Press, 33rd edition, 2002.
  2. Y. P. Singla, M. Kumar, and B. Singh, “Formulation and in vitro evaluation of gastroretentive drug delivery system of Cefixime trihydrate,” International Journal of Drug Development & Research, vol. 3, no. 4, pp. 148–161, 2011. View at Google Scholar · View at Scopus
  3. A. Ateshkadi and N. P. Lam, “Helicobacter pylori and peptic ulcer disease,” Clinical Pharmacology, vol. 12, pp. 34–48, 1993. View at Google Scholar
  4. S. C. Arora, “Development, characterization and andsolubility and solid dispersions of cefixime trihydrate by solvent method,” International Journal of Drug Development & Research, vol. 2, pp. 424–430, 2010. View at Google Scholar
  5. S. S. Mohammed, G. V. Reddy, and K. V. Pranush, “Comparison of solubility improvement of cefixime and omeprazole magnesium by solid dispersion and slugging method,” International Journal of Research in Pharmaceutical and Nano Sciences, vol. 3, no. 1, pp. 50–60, 2014. View at Google Scholar
  6. S. Mohanty, R. Mohapatra, S. Patra, and D. K. Sahoo, “Formulation and in-vitro evaluation of azithromycin mouth dissolving tablets using superdisintegrants,” Research Journal of Pharmaceutical, Biological & Chemical Sciences, vol. 4, no. 3, pp. 452–461, 2013. View at Google Scholar · View at Scopus
  7. H. R. Pouretedal, “Preparation and characterization of azithromycin nanodrug using solvent/antisolvent method,” International Nano Letters, vol. 4, no. 1, pp. 103–111, 2014. View at Publisher · View at Google Scholar
  8. M. Abhilash, “Potential applications of nanoparticles,” International Journal of Pharma and Bio Sciences, vol. 1, no. 1, article 53, 11 pages, 2010. View at Google Scholar · View at Scopus
  9. Y. Thorat, D. Gonjari, and A. Hosmani, “Solubility enhancement techniques: a review on conventional and novel approaches,” International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 10, pp. 2501–2513, 2011. View at Google Scholar
  10. J.-X. Wang, Q.-X. Zhang, Y. Zhou, L. Shao, and J.-F. Chen, “Microfluidic synthesis of amorphous cefuroxime axetil nanoparticles with size-dependent and enhanced dissolution rate,” Chemical Engineering Journal, vol. 162, no. 2, pp. 844–851, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. A. Overhoff, R. O. Johnston, and R. O. Williams, “Improvement of dissolution rate of poorly water soluble drugs using a new particle engineering process: spray freezing into liquid,” in Polymeric Drug Delivery II, pp. 305–319, 2006. View at Google Scholar
  12. G. G. Liversidge and C. K. Cundy, “Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: absolute oral bioavailability of nanocrystalline Danzol in beagle dogs,” International Journal of Pharmaceutics, vol. 125, pp. 91–97, 1995. View at Google Scholar
  13. A. A. Noyes and W. R. Whitney, “The rate of solution of solid substances in their own solutions,” Journal of the American Chemical Society, vol. 19, no. 12, pp. 930–934, 1897. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Buzea, I. I. Pacheco, and K. Robbie, “Nanomaterials and nanoparticles: sources and toxicity,” Biointerphases, vol. 2, no. 4, pp. 17–71, 2007. View at Publisher · View at Google Scholar
  15. P. Christian, F. V. Kammer, M. Baalousha, and Th. Hofmann, “Nanoparticles: structure, properties, preparation and behaviour in environmental media,” Ecotoxicology, vol. 17, no. 5, pp. 326–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Kesisoglou, S. Panmai, and Y. Wu, “Nanosizing—oral formulation development and biopharmaceutical evaluation,” Advanced Drug Delivery Reviews, vol. 59, no. 7, pp. 631–644, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Panagiotou and R. J. Fisher, “Producing micron- and nanosize formulations for functional foods applications,” Functional Foods in Health and Disease, vol. 3, pp. 274–289, 2013. View at Google Scholar
  18. L. Hixon, M. Prior, H. Prem, and J. Vancleef, “Sizing materials by crushing and grinding,” Chemical Engineering Journal, vol. 97, pp. 94–103, 1990. View at Google Scholar
  19. D. Horn and J. Rieger, “Organic nanoparticles in the aqueous phase—theory, experiment, and use,” Angewandte Chemie—International Edition, vol. 40, no. 23, pp. 4330–4361, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. T. L. Rogers, I. B. Gillespie, J. E. Hitt et al., “Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs,” Pharmaceutical Research, vol. 21, no. 11, pp. 2048–2057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Merisko-Liversidge, G. G. Liversidge, and E. R. Cooper, “Nanosizing: a formulation approach for poorly-water-soluble compounds,” European Journal of Pharmaceutical Sciences, vol. 18, no. 2, pp. 113–120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Thorat and S. V. Dalvi, “Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective,” Chemical Engineering Journal, vol. 181-182, pp. 1–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Reverchon, “Supercritical antisolvent precipitation of micro- and nano-particles,” The Journal of Supercritical Fluids, vol. 15, no. 1, pp. 1–21, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kakran, N. G. Sahoo, I.-L. Tan, and L. Li, “Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods,” Journal of Nanoparticle Research, vol. 14, no. 3, pp. 757–768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-Y. Kuang, Z.-B. Zhang, M.-L. Xie, J.-X. Wang, Y. Le, and J.-F. Chen, “Large-scale preparation of amorphous cefixime nanoparticles by antisolvent precipitation in a high-gravity rotating packed bed,” Industrial and Engineering Chemistry Research, vol. 54, no. 33, pp. 8157–8165, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Mehta, A. More, and A. Kulkarni, “Effect of hydrophilic polymers on cefixime complexation with β-cyclodextrin,” International Journal of Current Pharmaceutical Research, vol. 5, no. 3, pp. 66–70, 2013. View at Google Scholar
  27. Y. Paul, M. Kumar, and B. Singh, “Formulation, evaluation and study of effect of hydrophilic polymers on release rate of cefixime floating tablets,” International Journal of Pharma & Bio Sciences, vol. 2, no. 4, pp. 472–488, 2011. View at Google Scholar · View at Scopus
  28. S. Verma, A. Kumar, V. K. Malik, and V. Kumar, “Compritrol ATO 888 based solid lipid nanoparticles of cefixime: formulation and evaluation,” Der Pharmacia Sinica, vol. 4, no. 3, pp. 8–13, 2013. View at Google Scholar
  29. S. Timoumi, D. Mangin, R. Peczalski, F. Zagrouba, and J. Andrieu, “Stability and thermophysical properties of azithromycin dihydrate,” Arabian Journal of Chemistry, vol. 7, no. 2, pp. 189–195, 2014. View at Publisher · View at Google Scholar · View at Scopus